Version: 1.0.0 | Published: 5 Oct 2026 | Updated: 0 days ago
Documentation
Description:
**Experiment type**: Expression profiling by high throughput sequencing
**Summary**: Microglia play a key role in the pathophysiology of Alzheimer’s Disease (AD) and their increased heterogeneity likely affects disease progression. We previously identified distinct microglial signatures that were enriched in AD donors and associated with amyloid and tau, respectively. Here we analyzed cell-cell communication pathways that might be relevant to AD pathophysiology. We generated a snRNAseq dataset from postmortem control and AD cases and analyzed alterations in cell-cell communications. One signaling pathway perturbed in AD cases involved SPP1, and while this pathway was also present in control samples, microglia-microglia SPP1 signaling was restricted to AD donors. Further analyses within microglia-microglia signaling predict AD-specific induction of GAS6-AXL signaling (from inflammatory and ribosomal microglia), and SPP1-ITGAV/ITGB5 signaling (from disease-associated and inflammatory microglia, among others). Together, these findings might in part explain the increased microglia phagocytic profile described in AD.
**Overall design**: Single-nucleus RNAseq transcriptomes were generated from fresh frozen occipitotemporal cortex brain samples. A total of ten samples were processed, five from donors with Alzheimer"s disease, and five from non-neurological controls.
Coverage
Spatial:
US
Follow Up:
Unknown
Provenance
Temporal
Accrual Periodicity:
Static
Start Date:
01 January 2026
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
See dataset for details. Access data at:
Usage
Resource Creators:
Bart Eggen
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
0
Count
01 January 2026